About BioTissue
BioTissue is a Healthcare company based in Miami (United States) founded in 2001 by Amy Tseng and Scheffer CG Tseng. Regenerative biologic therapies for eye care are developed and provided. It operates on a Direct-to-Consumer (D2C) and Professional Services model. BioTissue has raised $110.04 million across 19 funding rounds from investors including HHS, EW Healthcare Partners and Ballast Point Ventures. BioTissue offers products and services including Prokera, AmnioGraft, Neox 100, and Clarix 100. Its focus areas include Biotechnology and Regenerative Medicine. Its competitors include Annexon, Aldeyra and Gyroscope; 2 of its 3 listed competitors have raised funding.
Company details
BioTissue is engaged in the development and delivery of regenerative healing solutions using human birth tissue products. The company operates in the healthcare sector, specifically within biotechnology and regenerative medicine. Its offerings include ocular and surgical products such as Prokera, AmnioGraft, Neox, and Clarix, which are designed to support tissue repair and healing. Proprietary technologies like CryoTek are utilized to preserve the natural structure and biology of tissues. Research and development efforts are emphasized, with over 40 years of experience and more than 1 million clinical applications recorded.
- Headquarters Miami, United States
- Founders Amy Tseng, Scheffer CG Tseng
- SectorsHealthcare
- Phone•••• ••••
- Website biotissue.com
- Social LinkedIn X Facebook YouTube
- Legal Name Biotissue
- Total Equity Funding$110.04M (USD)
in 19 rounds
- Latest Funding Round$4.42M (USD), Grant
Jun 2021
- InvestorsHHS
& 3 more
Products & Services of BioTissue
BioTissue offers a comprehensive portfolio of products and services, including Prokera, AmnioGraft, Neox 100, and Clarix 100.
Used for ocular healing with regenerative tissue technology.
Applied in ocular treatments for tissue regeneration support.
Utilized in surgical procedures for regenerative tissue healing.
Employed in surgical applications for tissue repair solutions.
Apps and channels of BioTissue
its YouTube channel BioTissue has 3.45K subscribers and 30 videos.
Videos from BioTissue
The most watched videos on BioTissue's YouTube channel, BioTissue (3.45K subscribers). Click a video to play it here.
More on BioTissue.
Funding Insights of BioTissue
BioTissue has successfully raised a total of $110.04M across 19 strategic funding rounds. The most recent funding activity was a Grant round of $4.42 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $110.04M
- Total Rounds 19
- Last Round Grant — $4.42M
- First Round $935,580
(Sep 2006)
- Investors Count 4
Latest 10 of 19 funding rounds of BioTissue with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2021 | $4.42M | Grant | – | – | |
| Apr 2019 | $82.25M | Series C | – | EW Healthcare Partners | |
| Nov 2016 | $4.42M | Grant | – | – | |
| Jun 2015 | $15M | Series B | – | River Cities Capital, Ballast Point Ventures | – |
| May 2015 | $1.29M | Grant | – | – | |
| Oct 2013 | $1.42M | Series A | – | – | – |
| Aug 2013 | $10M | Series A | – | River Cities Capital, Ballast Point Ventures | – |
| Oct 2012 | $1.37M | Seed | – | – | – |
| Jun 2012 | $1.42M | Grant | – | – | |
| May 2012 | $997,132 | Grant | – | – |
4 investors in total: 4 institutional.
Investors in BioTissue
BioTissue has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, EW Healthcare Partners and Ballast Point Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth-stage healthcare companies are invested in by EW Healthcare Partners. | ewhealthcare.com | New York, United States | ||
Expansion capital is provided by Ballast Point Ventures to growing companies. | ballastpointventures.com | Tampa, United States | ||
| rccf.com | ||||
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for BioTissue
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BioTissue
69 people are tracked at BioTissue (29 in leadership, 4 in board & advisors, 36 in team).
| Name | Role | Group |
|---|---|---|
Amy Tseng | Co-Founder | Leadership |
Scheffer CG Tseng | Co-Founder | Leadership |
Randy Mansfield | Sr. Director, Marketing Content | Leadership |
Rodrigo Arbenoiz | Senior Director, Fp&a | Leadership |
Angelica Gongora | Sr. People Business Partner | Leadership |
Meghan L. | Area/us Vice President- Surgical Sales | Leadership |
Sean Tighe | Sr. Director | Leadership |
Angela Parra | Senior Director Commercial Operations | Leadership |
Ben Barney | Regional Sales Director | Leadership |
Tim Hunter | Vice President, Reimbursement & Government Affairs | Leadership |
Krista Roberts | Senior Vice President Operations | Leadership |
Juan Colon | Supply Chain Director | Leadership |
Brandon Caraway Sr. | Vice President Of Sales | Leadership |
Ted Davis | President & CEO | Leadership |
Michael Cornelius | CFO | Leadership |
Laurie Minott | Chief People Officer | Leadership |
Tiffany Matthews | Vice President Marketing | Leadership |
Michael Perez | Sr. Director, IT Operations And Security | Leadership |
Jessica McLain | Senior Talent Acquisition Business Partner | Leadership |
Chris Woolard | Regional Sales Director | Leadership |
49 more people are available in the full profile.
Complete people profiles for BioTissue
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BioTissue
3 dated milestones of BioTissue across 20 years, from founding to its latest funding, stage changes and deals.
- Founded BioTissue is founded.
- Funding First funding round of $936K.
- Funding Latest funding round, Grant, of $4.4M.
Competitors of BioTissue
BioTissue has 3 listed competitors in our database, 2 of them funded. They include Annexon, Aldeyra and Gyroscope.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| annexonbio.com | 2011 | San Francisco, United States | $256M | 80 | Developer of antibodies to treat complement-mediated neurodegenerative diseases | |
| aldeyra.com | 2004 | Lexington, United States | $4.79M | 30 | Drug candidates for immune-mediated diseases are developed by Aldeyra. | |
| gyroscope.cc | 2016 | San Francisco, United States | Mobile SDK developed for app engagement and monetization strategies. |
Detailed competitors of BioTissue
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BioTissue
The website of BioTissue (biotissue.com) receives about 8.6K visits a month.
- Monthly visits8.6K
▲ 10.3% vs previous month
Websites whose visitors overlap most with BioTissue. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
codingahead.com | codingahead.com | 100% | #10,127,520 | – | |
biotimeinc.com | biotimeinc.com | 91% | – | ||
optometrytimes.com | optometrytimes.com | 90% | #696,650 | – | |
| lifecell.com | 85% | View details | |||
astym.com | astym.com | 84% | #2,545,761 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for BioTissue
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Wound Care
3 companies that operate in the same segment as BioTissue (Wound Care) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | 35 | ||
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | USD 418.63 M | 837 | ||
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biotissue
Complete news archive for BioTissue
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioTissue
BioTissue was founded in 2001 and raised its 1st funding round 5 years after it was founded.
BioTissue is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
BioTissue is a funded company, having raised a total of $110.04M across 19 funding rounds to date. The company's 1st funding round was a Grant of $997.13K, raised on Sep 2006.
BioTissue is engaged in the development and delivery of regenerative healing solutions using human birth tissue products. The company operates in the healthcare sector, specifically within biotechnology and regenerative medicine. Its offerings include ocular and surgical products such as Prokera, AmnioGraft, Neox, and Clarix, which are designed to support tissue repair and healing. Proprietary technologies like CryoTek are utilized to preserve the natural structure and biology of tissues. Research and development efforts are emphasized, with over 40 years of experience and more than 1 million clinical applications recorded.
BioTissue offers Prokera, AmnioGraft, Neox 100, and Clarix 100.
BioTissue has 4 investors. Key investors include HHS, EW Healthcare Partners, Ballast Point Ventures, and River Cities Capital.
BioTissue operates through Biotissue.